PANews reported on November 24th that, according to The Block, Nasdaq-listed biopharmaceutical company Enlivex Therapeutics announced it will raise $212 million through a PIPE private placement to purchase Rain tokens as the core reserve for its Digital Asset Vault (DAT). The company claims the project is the first DAT built around a prediction market token. Rain is a decentralized prediction market protocol on the Arbitrum blockchain. Following the completion of this fundraising, former Italian Prime Minister Matteo Renzi will join the Enlivex board of directors.